$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Inflammation as death or life signal in diabetic fracture healing

Inflammation research : official journal of the European Histamine Research Society ... [et al.], v.60 no.1, 2011년, pp.3 - 10  

Rőszer, Tamás

초록이 없습니다.

참고문헌 (99)

  1. Clin Oral Implants Res M Retzepi 21 7 673 2010 10.1111/j.1600-0501.2010.01923.x Retzepi M, Donos N. The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res. 2010;21(7):673-81. 

    상세보기 crossref

  2. Folia Med (Plovdiv) NP Botushanov 51 12 2009 Botushanov NP, Orbetzova MM. Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus. Folia Med (Plovdiv). 2009;51:12-7. 

  3. Calcif Tissue Int R Bouillon 49 155 1991 10.1007/BF02556109 Bouillon R. Diabetic bone disease. Calcif Tissue Int. 1991;49:155-60. 

    상세보기 crossref

  4. Med Sci Monit S Yaturu 15 CR5 2009 Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit. 2009;15:CR5-9. 

  5. Clin Orthop Relat Res RT Loder 232 210 1988 10.1097/00003086-198807000-00028 Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res. 1988;232:210-6. 

    상세보기 crossref

  6. J Orthop Trauma JW Folk 13 369 1999 10.1097/00005131-199906000-00008 Folk JW, Starr AJ, Early JS. Early wound complications of operative treatment of calcaneus fractures: analysis of 190 fractures. J Orthop Trauma. 1999;13:369-72. 

    상세보기 crossref

  7. Orthop Clin North Am AY Ketenjian 9 43 1978 10.1016/S0030-5898(20)30880-4 Ketenjian AY, Jafri AM, Arsenis C. Studies on the mechanism of callus cartilage differentiation and calcification during fracture healing. Orthop Clin North Am. 1978;9:43-65. 

    상세보기 crossref

  8. 10.1002/jbmr.59 Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D, et al. TNF-alpha mediates diabetes enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO-1. J Bone Miner Res. 2010;25:1604-15. 

    상세보기 crossref

  9. Bone RA Kayal 44 357 2009 10.1016/j.bone.2008.10.042 Kayal RA, Alblowi J, McKenzie E, Krothapalli N, Silkman L, Gerstenfeld L, et al. Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone. 2009;44:357-63. 

    상세보기 crossref

  10. Cells Tissues Organs A Stolzing 191 453 2010 10.1159/000281826 Stolzing A, Sellers D, Llewelyn O, Scutt A. Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs. 2010;191:453-65. 

    상세보기 crossref

  11. Bone Y Hamada 45 Suppl 1 S35 2009 10.1016/j.bone.2009.02.004 Hamada Y, Fujii H, Fukagawa M. Role of oxidative stress in diabetic bone disorder. Bone. 2009;45(Suppl 1):S35-8. 

    상세보기 crossref

  12. Curr Drug Metab SA Sheweita 8 519 2007 10.2174/138920007780866852 Sheweita SA, Khoshhal KI. Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab. 2007;8:519-25. 

    상세보기 crossref

  13. Med Hypotheses S Yamagishi 65 1013 2005 10.1016/j.mehy.2005.07.017 Yamagishi S, Nakamura K, Inoue H. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses. 2005;65:1013-5. 

    상세보기 crossref

  14. 10.1007/s12575-009-9000-5 Motyl K, McCabe LR. Streptozotocin, type I diabetes severity and bone. Biol Proced Online. 2009. [Epub ahead of print]. 

    상세보기 crossref

  15. Pathophysiol Haemost Thromb I Juhan-Vague 32 269 2002 10.1159/000073579 Juhan-Vague I, Morange PE, Alessi MC. The insulin resistance syndrome: implications for thrombosis and cardiovascular disease. Pathophysiol Haemost Thromb. 2002;32:269-73. 

    상세보기 crossref

  16. Curr Dir Autoimmun T Tzanavari 11 145 2010 10.1159/000289203 Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun. 2010;11:145-56. 

    상세보기 crossref

  17. Mediat Inflamm H Kaneto 2010 453892 2010 10.1155/2010/453892 Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm. 2010;2010:453892. 

    상세보기 crossref

  18. 10.1007/s00592-010-0198-0 Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z. The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol. 2010. [Epub ahead of print]. 

    상세보기 crossref

  19. Nat Rev Endocrinol T Mandrup-Poulsen 6 158 2010 10.1038/nrendo.2009.271 Mandrup-Poulsen T, Pickersgill L, Donath MY. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol. 2010;6:158-66. 

    상세보기 crossref

  20. 10.1016/j.immuni.2010.04.001 Todd JA. Etiology of type 1 diabetes. Immunity.2010;32:457-67. 

    상세보기 crossref

  21. 10.1007/s00535-009-0193-9 Takino JI, Kobayashi Y, Takeuchi M. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity. J Gastroenterol. 2010;45:646-55. 

    상세보기 crossref

  22. Hasnan J, Yusof MI, Damitri TD, Faridah AR, Adenan AS, Norbaini TH. Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J; 51:50-5. 

  23. Diabetes Metab Res Rev M Civera 26 187 2010 10.1002/dmrr.1070 Civera M, Urios A, Garcia-Torres ML, Ortega J, Martinez-Valls J, Cassinello N, et al. Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity. Diabetes Metab Res Rev. 2010;26:187-92. 

    상세보기 crossref

  24. J Dent Res T Desta 89 609 2010 10.1177/0022034510362960 Desta T, Li J, Chino T, Graves DT. Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. J Dent Res. 2010;89:609-14. 

    상세보기 crossref

  25. J Leukoc Biol BM Burgering 73 689 2003 10.1189/jlb.1202629 Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003;73:689-701. 

    상세보기 crossref

  26. 10.1172/JCI39901 Rached MT, Kode A, Silva BC, Jung DY, Gray S, Ong H, et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest. (2010) 120:357-68. 

    상세보기 crossref

  27. Am J Pathol FJ Blanco 146 75 1995 Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995;146:75-85. 

    상세보기

  28. Clin Orthop Relat Res MB Goldring 427 S37 2004 10.1097/01.blo.0000144484.69656.e4 Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004;427:S37-46. 

    상세보기 crossref

  29. 10.1007/s00011-010-0156-x Peng H, Zhou JL, Liu SQ, Hu QJ, Ming JH, Qiu B. Hyaluronic acid inhibits nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes in vitro. Inflamm Res; 59:519-30. 

    상세보기 crossref

  30. J Biol Chem S Wu 283 34037 2008 10.1074/jbc.M803754200 Wu S, Fadoju D, Rezvani G, De Luca F. Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65. J Biol Chem. 2008;283:34037-44. 

    상세보기 crossref

  31. Eur J Clin Nutr A Nilsson 48 Suppl 1 S150 1994 Nilsson A, Ohlsson C, Isaksson OG, Lindahl A, Isgaard J. Hormonal regulation of longitudinal bone growth. Eur J Clin Nutr. 1994;48(Suppl 1):S150-8. discussion S158-60. 

  32. 10.2174/1874609811003010026 Iwata K, Asawa Y, Fujihara Y, Tanaka Y, Nishizawa S, Nakagawa T, et al. The effects of rapid- or intermediate-acting insulin on the proliferation and differentiation of cultured chondrocytes. Curr Aging Sci. 2010;3:26-33. 

    crossref

  33. Perit Dial Int G Rashid 21 122 2001 10.1177/089686080102100203 Rashid G, Luzon AA, Korzets Z, Klein O, Zeltzer E, Bernheim J. The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages. Perit Dial Int. 2001;21:122-9. 

    상세보기 crossref

  34. Arthritis Res Ther C Csaki 11 R165 2009 10.1186/ar2850 Csaki C, Mobasheri A, Shakibaei M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 2009;11:R165. 

    상세보기 crossref

  35. Eur J Pharmacol MV Gangoiti 600 140 2008 10.1016/j.ejphar.2008.10.031 Gangoiti MV, Cortizo AM, Arnol V, Felice JI, McCarthy AD. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells. Eur J Pharmacol. 2008;600:140-7. 

    상세보기 crossref

  36. 10.1016/j.bbrc.2010.03.152 Puddu A, Storace D, Odetti P, Viviani GL. Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochem Biophys Res Commun. 2010;395:122-5. 

    상세보기 crossref

  37. Am J Pathol M Torreggiani 175 1722 2009 10.2353/ajpath.2009.090138 Torreggiani M, Liu H, Wu J, Zheng F, Cai W, Striker G, et al. Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol. 2009;175:1722-32. 

    상세보기 crossref

  38. 10.1146/annurev.nutr.012809.104755 Aggarwal BB. Targeting Inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010;30:173-99. 

    상세보기 crossref

  39. Eur J Endocrinol D Hofso 161 451 2009 10.1530/EJE-09-0421 Hofso D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, et al. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol. 2009;161:451-8. 

    상세보기 crossref

  40. Ann N Y Acad Sci BF Boyce 1192 367 2010 10.1111/j.1749-6632.2009.05315.x Boyce BF, Yao Z, Xing L. Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci. 2010;1192:367-75. 

    상세보기 crossref

  41. Biochem Biophys Res Commun SJ Kim 296 221 2002 10.1016/S0006-291X(02)00824-0 Kim SJ, Im DS, Kim SH, Ryu JH, Hwang SG, Seong JK, et al. Beta-catenin regulates expression of cyclooxygenase-2 in articular chondrocytes. Biochem Biophys Res Commun. 2002;296:221-6. 

    상세보기 crossref

  42. Arthritis Rheum N Wehling 60 801 2009 10.1002/art.24352 Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, Muller PE, et al. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum. 2009;60:801-12. 

    상세보기 crossref

  43. Biochem Pharmacol SJ Cullen 79 706 2010 10.1016/j.bcp.2009.10.006 Cullen SJ, Ponnappan S, Ponnappan U. Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation. Biochem Pharmacol. 2010;79:706-14. 

    상세보기 crossref

  44. 10.1126/science.1182364 Shembade N, Ma A, Harhaj EW. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science; 327:1135-9. 

    상세보기 crossref

  45. Endocrinology S Wu 147 3761 2006 10.1210/en.2005-1672 Wu S, De Luca F. Inhibition of the proteasomal function in chondrocytes down-regulates growth plate chondrogenesis and longitudinal bone growth. Endocrinology. 2006;147:3761-8. 

    상세보기 crossref

  46. Metabolism TL Chang 58 1643 2009 10.1016/j.metabol.2009.05.020 Chang TL, Chang CJ, Lee WY, Lin MN, Huang YW, Fan K. The roles of ubiquitin and 26S proteasome in human obesity. Metabolism. 2009;58:1643-8. 

    상세보기 crossref

  47. Obesity (Silver Spring) K Sakamoto 17 1044 2009 10.1038/oby.2008.612 Sakamoto K, Sato Y, Shinka T, Sei M, Nomura I, Umeno M, et al. Proteasome subunits mRNA expressions correlate with male BMI: implications for a role in obesity. Obesity (Silver Spring). 2009;17:1044-9. 

    상세보기 crossref

  48. Toxicol Appl Pharmacol AP Rolo 212 167 2006 10.1016/j.taap.2006.01.003 Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167-78. 

    상세보기 crossref

  49. Curr Hypertens Rep G Soldatos 7 96 2005 10.1007/s11906-005-0081-5 Soldatos G, Cooper ME, Jandeleit-Dahm KA. Advanced-glycation end products in insulin-resistant states. Curr Hypertens Rep. 2005;7:96-102. 

    상세보기 crossref

  50. Biochem Soc Trans L Webster 25 250S 1997 10.1042/bst025250s Webster L, Abordo EA, Thornalley PJ, Limb GA. Induction of TNF alpha and IL-1 beta mRNA in monocytes by methylglyoxal- and advanced glycated endproduct-modified human serum albumin. Biochem Soc Trans. 1997;25:250S. 

    상세보기 crossref

  51. Bone M Alikhani 40 345 2007 10.1016/j.bone.2006.09.011 Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone. 2007;40:345-53. 

    상세보기 crossref

  52. Diabetes RB Santana 52 1502 2003 10.2337/diabetes.52.6.1502 Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes. 2003;52:1502-10. 

    상세보기 crossref

  53. J Cell Biochem WH Chan 100 1056 2007 10.1002/jcb.21114 Chan WH, Wu HJ, Shiao NH. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem. 2007;100:1056-69. 

    상세보기 crossref

  54. Cell Metab E Ambrogini 11 136 2010 10.1016/j.cmet.2009.12.009 Ambrogini E, Almeida M, Martin-Millan M, Paik JH, Depinho RA, Han L, et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010;11:136-46. 

    상세보기 crossref

  55. J Clin Endocrinol Metab I Kanazawa 94 45 2009 10.1210/jc.2008-1455 Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:45-9. 

    상세보기 crossref

  56. 10.1007/s00198-010-1184-7 Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2010. [Epub ahead of print]. 

    상세보기 crossref

  57. 10.1046/j.1365-2567.2001.01261.x van’t Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001; 103:255-61. 

    상세보기 crossref

  58. Endocrinology F Grassi 147 4392 2006 10.1210/en.2006-0334 Grassi F, Fan X, Rahnert J, Weitzmann MN, Pacifici R, Nanes MS, et al. Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(−/−) mouse. Endocrinology. 2006;147:4392-9. 

    상세보기 crossref

  59. Bone Y Baldik 37 32 2005 10.1016/j.bone.2004.10.002 Baldik Y, Diwan AD, Appleyard RC, Fang ZM, Wang Y, Murrell GA. Deletion of iNOS gene impairs mouse fracture healing. Bone. 2005;37:32-6. 

    상세보기 crossref

  60. J Cell Biochem P Collin-Osdoby 57 399 1995 10.1002/jcb.240570305 Collin-Osdoby P, Nickols GA, Osdoby P. Bone cell function, regulation, and communication: a role for nitric oxide. J Cell Biochem. 1995;57:399-408. 

    상세보기 crossref

  61. Diabetes A Charbonneau 59 861 2010 10.2337/db09-1238 Charbonneau A, Marette A. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes. 2010;59:861-71. 

    상세보기 crossref

  62. J Cardiometab Syndr K Nishio 3 200 2008 10.1111/j.1559-4572.2008.00019.x Nishio K, Shigemitsu M, Kodama Y, Itoh S, Konno N, Satoh R, et al. The effect of pioglitazone on nitric oxide synthase in patients with type 2 diabetes mellitus. J Cardiometab Syndr. 2008;3:200-4. 

    상세보기 crossref

  63. 10.1002/jbt.20340 Son MJ, Lee SB, Byun YJ, Lee HO, Kim HS, Kwon OJ, et al. Sodium nitroprusside induces autophagic cell death in glutathione-depleted osteoblasts. J Biochem Mol Toxicol. 2010. [Epub ahead of print]. 

    상세보기 crossref

  64. Pharmacol Ther DG Farmer 124 185 2009 10.1016/j.pharmthera.2009.06.013 Farmer DG, Kennedy S. RAGE, vascular tone and vascular disease. Pharmacol Ther. 2009;124:185-94. 

    상세보기 crossref

  65. Biochim Biophys Acta BE Rapuano 1091 374 1991 10.1016/0167-4889(91)90203-A Rapuano BE, Bockman RS. Tumor necrosis factor-alpha stimulates phosphatidylinositol breakdown by phospholipase C to coordinately increase the levels of diacylglycerol, free arachidonic acid and prostaglandins in an osteoblast (MC3T3-E1) cell line. Biochim Biophys Acta. 1991;1091:374-84. 

    상세보기 crossref

  66. Clin Cancer Res SW Shin 15 5414 2009 10.1158/1078-0432.CCR-08-3101 Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, et al. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res. 2009;15:5414-25. 

    상세보기 crossref

  67. Toxicology SJ Lee 248 121 2008 10.1016/j.tox.2008.03.014 Lee SJ, Kim MS, Park JY, Woo JS, Kim YK. 15-Deoxy-delta 12, 14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells. Toxicology. 2008;248:121-9. 

    상세보기 crossref

  68. Annu Rev Physiol JM Olefsky 72 219 2010 10.1146/annurev-physiol-021909-135846 Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219-46. 

    상세보기 crossref

  69. Biochim Biophys Acta S Heikkinen 1771 999 2007 10.1016/j.bbalip.2007.03.006 Heikkinen S, Auwerx J, Argmann CA. PPARgamma in human and mouse physiology. Biochim Biophys Acta. 2007;1771:999-1013. 

    상세보기 crossref

  70. J Clin Invest LC Bell-Parikh 112 945 2003 10.1172/JCI200318012 Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, FitzGerald GA. Biosynthesis of 15-deoxy-delta12, 14-PGJ2 and the ligation of PPARgamma. J Clin Invest. 2003;112:945-55. 

    상세보기 crossref

  71. Toxicology JY Jung 234 73 2007 10.1016/j.tox.2007.02.005 Jung JY, Yoo CI, Kim HT, Kwon CH, Park JY, Kim YK. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death. Toxicology. 2007;234:73-82. 

    상세보기 crossref

  72. Toxicol Appl Pharmacol SH Kim 215 198 2006 10.1016/j.taap.2006.03.001 Kim SH, Yoo CI, Kim HT, Park JY, Kwon CH, Kim YK. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells. Toxicol Appl Pharmacol. 2006;215:198-207. 

    상세보기 crossref

  73. Bone TH Lin 41 562 2007 10.1016/j.bone.2007.06.017 Lin TH, Yang RS, Tang CH, Lin CP, Fu WM. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone. 2007;41:562-74. 

    상세보기 crossref

  74. J Cell Physiol KH Szymczyk 209 836 2006 10.1002/jcp.20770 Szymczyk KH, Freeman TA, Adams CS, Srinivas V, Steinbeck MJ. Active caspase-3 is required for osteoclast differentiation. J Cell Physiol. 2006;209:836-44. 

    상세보기 crossref

  75. Clin Endocrinol (Oxf) C Cloos 48 317 1998 10.1046/j.1365-2265.1998.00374.x Cloos C, Wahl P, Hasslacher C, Traber L, Kistner M, Jurkuhn K, et al. Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus. Clin Endocrinol (Oxf). 1998;48:317-23. 

    상세보기 crossref

  76. J Endocrinol Invest SA Kemink 23 295 2000 10.1007/BF03343726 Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest. 2000;23:295-303. 

    상세보기 crossref

  77. J Dent Res R Liu 85 510 2006 10.1177/154405910608500606 Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006;85:510-4. 

    상세보기 crossref

  78. Cell Death Differ E Luegmayr 11 Suppl 1 S108 2004 10.1038/sj.cdd.4401399 Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE, Rodan GA, et al. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ. 2004;11(Suppl 1):S108-18. 

    상세보기 crossref

  79. Eur J Pharmacol M Hie 621 1 2009 10.1016/j.ejphar.2009.08.025 Hie M, Yamazaki M, Tsukamoto I. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes. Eur J Pharmacol. 2009;621:1-9. 

    상세보기 crossref

  80. Bone Y Kawashima 44 648 2009 10.1016/j.bone.2008.12.012 Kawashima Y, Fritton JC, Yakar S, Epstein S, Schaffler MB, Jepsen KJ, et al. Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis. Bone. 2009;44:648-55. 

    상세보기 crossref

  81. Endocrinology J Cornish 149 5688 2008 10.1210/en.2008-0111 Cornish J, MacGibbon A, Lin JM, Watson M, Callon KE, Tong PC, et al. Modulation of osteoclastogenesis by fatty acids. Endocrinology. 2008;149:5688-95. 

    상세보기 crossref

  82. Ann N Y Acad Sci H Wakeyama 1116 271 2007 10.1196/annals.1402.001 Wakeyama H, Akiyama T, Kadono Y, Nakamura M, Oshima Y, Nakamura K, et al. Posttranslational regulation of Bim by caspase-3. Ann N Y Acad Sci. 2007;1116:271-80. 

    상세보기 crossref

  83. J Bone Miner Res H Wakeyama 22 1631 2007 10.1359/jbmr.070619 Wakeyama H, Akiyama T, Takahashi K, Amano H, Kadono Y, Nakamura M, et al. Negative feedback loop in the Bim-caspase-3 axis regulating apoptosis and activity of osteoclasts. J Bone Miner Res. 2007;22:1631-9. 

    상세보기 crossref

  84. J Lipid Res SR Oh 51 892 2010 10.1194/jlr.M800626-JLR200 Oh SR, Sul OJ, Kim YY, Kim HJ, Yu R, Suh JH, et al. Saturated fatty acids enhance osteoclast survival. J Lipid Res. 2010;51:892-9. 

    상세보기 crossref

  85. 10.1210/en.2009-0813 Ruan M, Pederson L, Bradley EW, Bamberger AM, Oursler MJ. Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis. Endocrinology. 2010;151:1713-22. 

    상세보기 crossref

  86. 10.1016/j.tripleo.2009.10.042 Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JM, Garcia-Garcia A. RANK/RANKL/OPG role in distraction osteogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:679-86. 

    상세보기 crossref

  87. 10.3109/00365511003653599 Grauslund J, Rasmussen LM, Green A, Sjolie AK. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? Scand J Clin Lab Invest. 2010;70:188-93. 

    상세보기 crossref

  88. J Clin Periodontol DF Lappin 36 634 2009 10.1111/j.1600-051X.2009.01440.x Lappin DF, Eapen B, Robertson D, Young J, Hodge PJ. Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. J Clin Periodontol. 2009;36:634-41. 

    상세보기 crossref

  89. 10.1016/j.metabol.2009.09.019 Nabipour I, Kalantarhormozi M, Larijani B, Assadi M, Sanjdideh Z. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. Metabolism. 2010;59:742-7. 

    상세보기 crossref

  90. Exp Clin Endocrinol Diabetes HM Terekeci 117 119 2009 10.1055/s-0028-1085425 Terekeci HM, Senol MG, Top C, Sahan B, Celik S, Sayan O, et al. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy. Exp Clin Endocrinol Diabetes. 2009;117:119-23. 

    상세보기 crossref

  91. Eur J Endocrinol GM Jorgensen 161 95 2009 10.1530/EJE-09-0141 Jorgensen GM, Vind B, Nybo M, Rasmussen LM, Hojlund K. Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity. Eur J Endocrinol. 2009;161:95-101. 

    상세보기 crossref

  92. Exp Cell Res SK Lee 298 359 2004 10.1016/j.yexcr.2004.04.039 Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, et al. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Exp Cell Res. 2004;298:359-68. 

    상세보기 crossref

  93. J Bone Miner Res RJ van’t Hof 12 1797 1997 10.1359/jbmr.1997.12.11.1797 van’t Hof RJ, Ralston SH. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res. 1997;12:1797-804. 

    상세보기 crossref

  94. BMC Cell Biol KE Evans 8 4 2007 10.1186/1471-2121-8-4 Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 2007;8:4. 

    상세보기 crossref

  95. Nat Med Y Wan 13 1496 2007 10.1038/nm1672 Wan Y, Chong LW, Evans RM. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med. 2007;13:1496-503. 

    상세보기 crossref

  96. Toxicol Sci MA Peraza 90 269 2006 10.1093/toxsci/kfj062 Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci. 2006;90:269-95. 

    상세보기 crossref

  97. Horm Metab Res H Kaji 40 746 2008 10.1055/s-0028-1082051 Kaji H, Naito J, Inoue Y, Sowa H, Sugimoto T, Chihara K. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway. Horm Metab Res. 2008;40:746-51. 

    상세보기 crossref

  98. J Endocrinol Invest G Luisetto 32 32 2009 Luisetto G, Camozzi V. Statins, fracture risk, and bone remodeling. J Endocrinol Invest. 2009;32:32-7. 

    상세보기

  99. J Leukoc Biol MJ Hsu 87 1069 2010 10.1189/jlb.1009668 Hsu MJ, Chang CK, Chen MC, Chen BC, Ma HP, Hong CY, et al. Apoptosis signal-regulating kinase 1 in peptidoglycan-induced COX-2 expression in macrophages. J Leukoc Biol. 2010;87:1069-82. 

    상세보기 crossref
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로